Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by ANALIAS00on Feb 24, 2021 11:53pm
129 Views
Post# 32655270

RE:RE:RE:RE:RE:RE:RE:RE:I am getting the impression

RE:RE:RE:RE:RE:RE:RE:RE:I am getting the impressionFunny to see that you dont even consider the possibility that phase I can prove that the product is not working in human's body. You seem to ignore all possible issue with the plan with oncologie and nash. For sure it is less risky than the roulette but you must not ignore the risk. Nothing is a slam dunk. So you can act as a chearleader if you want. I can pom pom to and we can all pom pom to on this board, the thing is we are not a sport team here. It wont make any difference. We need management to deliver and they need also to manage to sell their story. And they may fail like many many many more before them. So we must react when we believe they are failing in some aspect. SP should catch up the gap eventually with others but can easily go back on bad news.

Last thing on the finance thing: If I have 2 diamond in my pocket that I believe worth 1 million each, if I sell the first one at $500 000, how do you think diamond investors will evaluate my second diamond ? I will give you another example.

You take a broker to sell you 2 identical houses on the same street, side by side. You and him evaluate your houses at $500 000 each no less. He has the responsability to sell your houses for you. He sells the first one at $300 000 and tells you not to be worry, we will soon sell the other one $700 000. Will you be happy ? Wont you think something is weird ? You will simply say well, its done now I MAY still have my 1 000 000 for my 2 houses as planned.

Ok I stop now ... It is a promesse :o)
FredTheVoice wrote: Along with JFM, and others, I dont put to much importance on that issue.

I respect the grief process of SPCEO and others, but the action of rebuilding credibilty, creating alliances, and going forward, looking at the big picture, means taking decisions with the reality in front of us...

Management took the best decision, and supported by the board, to build a better company. In french we have an expression thats goes like this: "facile de faire le gerant d'estrade". Easy to play the role, as if you were the leader, but actually sitting in the ground.

And I am pretty sure that their confidence is high and that Levesque's team all think the same: this year will be great for us and shareholders.

We will all see who's right before the end of year, and before summer we will have all the reasons to be happy.... I believe.

Palinc was hoping that Levesque's actions would take a couple of months to show effects.....I think, it was a year that was needed.......and that 2021, will be something, with is marks as CEO. The quality of new investors will be a sign, a strong one... and...

Sales another,

Yelling the story around another.

The rest will follow.....

And the stock price will continue its rise (because it is started....).

FTV.


<< Previous
Bullboard Posts
Next >>